Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 11 von 13

Details

Autor(en) / Beteiligte
Titel
Management of colorectal high-grade dysplasia or cancer resected by cold snare polypectomy: a multicenter exploratory study
Ist Teil von
  • Journal of gastroenterology, 2023-06, Vol.58 (6), p.554-564
Ort / Verlag
Singapore: Springer Nature Singapore
Erscheinungsjahr
2023
Quelle
MEDLINE
Beschreibungen/Notizen
  • Background The clinical course and surveillance strategy for patients who undergo cold snare polypectomy (CSP) for high-grade dysplasia (HGD) or cancer is unclear. We investigated the management of colorectal HGDs and cancers following CSP. Methods This Japanese nationwide multicenter exploratory study was retrospectively conducted on patients who had undergone CSP for colorectal HGDs or cancers and follow-up colonoscopy at least once from 2014 to 2020. We investigated the detection rate of CSP scars, local recurrence rate (LRR), risk factors for local recurrence, and follow-up strategy. This study was registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN000043670). Results We included 155 patients with 156 lesions. CSP scars were identified in 22 (31.4%), 41 (54.7%), and 10 (90.9%) patients with curative, borderline, and non-curative resection, respectively. Among them, residual tumors were observed in one (4.5%), six (14.6%), and three (30.0%) cases, respectively. The total LRR was 13.7% (95% confidence interval: 6.8–23.8). R1 resection cases (either horizontal or vertical margins positive for tumors) were associated with local recurrence ( p =  0.031). Salvage endoscopic and surgical resections were performed on 21 and 10 patients, respectively. Among them, the proportion of endoscopically suspected residual tumors was significantly higher ( p <  0.001) in the residual tumor-positive group (100%) than in the residual tumor-negative group (28.6%). Conclusions LRR after CSP for HGDs or cancers was 13.7% based on scar-identified cases. Salvage endoscopic or surgical resection should be performed according to the curability of the lesion and endoscopic findings during colonoscopic surveillance.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX